Search results
Summit Shares Soar After Cancer Drug Tops Merck’s Keytruda
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage...
Stocks of Local Interest
Clinton Herald, Iowa· 1 day agoJun. 3—Closing prices Monday: Adv Auto Parts 67.42 Abbott Labs 102.87 ADM 61.99 Ameriprise 431.04 AutoZone, Inc. 2,772.62 Boeing 184.57 Bank of America 39.88 BP PLC ADR 36.40 ConAgra Foods 29.73 ...
Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus...
Benzinga via Yahoo Finance· 5 days agoOn Friday, Summit Therapeutics Inc (NASDAQ:SMMT) shares are trading lower after the company’s stock...
Merck To Pay as Much as $3 Billion for Eye Treatment Startup
Bloomberg· 7 days agoHave a confidential tip for our reporters? Merck & Co. restocked its cabinet of eye treatments with...
Zentalis appoints new board member amid drug development By Investing.com
Investing.com· 7 days agoDr. Walker, currently the Chief Medical Officer at Harpoon Therapeutics (NASDAQ:HARP), a subsidiary...
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks via Yahoo Finance· 2 days agoThis ETF has heaviest allocation in the Healthcare sector--about 100% of the portfolio. Looking at...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 7 days agoHowever, Opdivo faces an upward climb as the urothelial cancer market is already dominated by Merck...
Summit Therapeutics' stock surges as lung-cancer treatment vies with Merck's blockbuster
Morningstar· 6 days agoShares of Summit Therapeutics Inc. (SMMT) jumped more than 270% Thursday after the company said its experimental cancer drug outperformed Merck & Co. Inc ...
Merck to buy EyeBio in a deal that could valued at up to $3 billion
Market Watch· 7 days agoannounced Wednesday an agreement to buy privately held Eyebiotech Ltd., an ophthalmology-focused...
Summit Therapeutics sees stock soar 272% after lung cancer clinical trial - Silicon Valley Business...
The Business Journals· 5 days ago(Nasdaq: SMMT) — led by the team that scored success with blood cancer drug developer Pharmacyclics...